Eurospital S.P.A.
Italian healthcare company (founded 1948) active in R&D, manufacture and commercialization of pharmaceuticals, medical devices, in‑vitro diagnostics, special nutrition (gluten‑free and low‑protein) and dietary supplements. Maintains internal R&D laboratories for diagnostic assay and molecular kit development, operates clinical and commercial distribution through pharmacy channels in Italy, collaborates with universities and research centers, and publishes periodic sustainability reports while holding multiple quality and regulatory certifications for international markets.
Industries
Nr. of Employees
medium (51-250)
Products
ELISA kits for infectious disease serology
Qualitative and quantitative ELISA kits for detection of antibodies against respiratory viruses, tropical viruses (Chikungunya, Dengue, Zika), hepatitis viruses (HDV, HEV), tick‑borne encephalitis (TBE), TORCH pathogens, and fungal/parasitic agents.
NS1 antigen ELISA for dengue
ELISA assay for detection of Dengue virus NS1 antigen in serum or plasma for early diagnosis of acute infection.
Microfluidic immunofluorescence antigen test and compatible reader
Microfluidics‑based immunofluorescence assay for detection of respiratory virus antigens from nasopharyngeal/oropharyngeal swabs, supplied with a compatible reader instrument for assay processing and signal reading.
Lateral‑flow rapid antigen and antibody tests with reader compatibility
Rapid immunochromatographic tests for antigen and antibody detection from blood or swab samples, offered in formats for self‑testing and professional use and compatible with automated lateral‑flow readers that enable traceability and report generation.
ELISA kits for TORCH and perinatal infection screening
ELISA assays for detection of antibodies to agents in the TORCH complex (Toxoplasma gondii, Rubella, Cytomegalovirus, Herpes simplex) including IgG/IgM and avidity formats for maternal‑fetal risk assessment.
ELISA kits for infectious disease serology
Qualitative and quantitative ELISA kits for detection of antibodies against respiratory viruses, tropical viruses (Chikungunya, Dengue, Zika), hepatitis viruses (HDV, HEV), tick‑borne encephalitis (TBE), TORCH pathogens, and fungal/parasitic agents.
NS1 antigen ELISA for dengue
ELISA assay for detection of Dengue virus NS1 antigen in serum or plasma for early diagnosis of acute infection.
Microfluidic immunofluorescence antigen test and compatible reader
Microfluidics‑based immunofluorescence assay for detection of respiratory virus antigens from nasopharyngeal/oropharyngeal swabs, supplied with a compatible reader instrument for assay processing and signal reading.
Lateral‑flow rapid antigen and antibody tests with reader compatibility
Rapid immunochromatographic tests for antigen and antibody detection from blood or swab samples, offered in formats for self‑testing and professional use and compatible with automated lateral‑flow readers that enable traceability and report generation.
ELISA kits for TORCH and perinatal infection screening
ELISA assays for detection of antibodies to agents in the TORCH complex (Toxoplasma gondii, Rubella, Cytomegalovirus, Herpes simplex) including IgG/IgM and avidity formats for maternal‑fetal risk assessment.
Services
Diagnostic assay and kit development
R&D, assay development and production of in‑vitro diagnostic kits across immunoassay, molecular and turbidimetric platforms for clinical laboratories and point‑of‑care settings.
Infectious disease serology and antigen testing supply
Development and supply of ELISA panels for viral, TORCH, fungal and parasitic serology; antigen detection assays for serum/plasma and swab specimens; and specialized serology tests including avidity assays.
Point‑of‑care rapid tests and reader integration
Supply of lateral‑flow rapid antigen and antibody tests, microfluidic immunofluorescence antigen tests and compatible reading instruments that support automated interpretation, sample traceability and reporting.
Special nutrition product development and supply
Formulation, registration and commercial supply of gluten‑free and low‑protein therapeutic foods intended for patients requiring specialized diets; products distributed through pharmacies and specialized retailers.
R&D collaboration, technical assistance and regulatory support
Collaborative research projects with universities and research centers, on‑demand technical support for laboratories and assistance with regulatory and quality matters related to diagnostics and special nutrition products.
Pharmacovigilance and adverse event reporting support
Operational processes and contact channels for reporting and managing adverse reaction reports and safety information, in line with legal requirements and involving external pharmacovigilance service providers where indicated.
Diagnostic assay and kit development
R&D, assay development and production of in‑vitro diagnostic kits across immunoassay, molecular and turbidimetric platforms for clinical laboratories and point‑of‑care settings.
Infectious disease serology and antigen testing supply
Development and supply of ELISA panels for viral, TORCH, fungal and parasitic serology; antigen detection assays for serum/plasma and swab specimens; and specialized serology tests including avidity assays.
Point‑of‑care rapid tests and reader integration
Supply of lateral‑flow rapid antigen and antibody tests, microfluidic immunofluorescence antigen tests and compatible reading instruments that support automated interpretation, sample traceability and reporting.
Special nutrition product development and supply
Formulation, registration and commercial supply of gluten‑free and low‑protein therapeutic foods intended for patients requiring specialized diets; products distributed through pharmacies and specialized retailers.
R&D collaboration, technical assistance and regulatory support
Collaborative research projects with universities and research centers, on‑demand technical support for laboratories and assistance with regulatory and quality matters related to diagnostics and special nutrition products.
Pharmacovigilance and adverse event reporting support
Operational processes and contact channels for reporting and managing adverse reaction reports and safety information, in line with legal requirements and involving external pharmacovigilance service providers where indicated.
Expertise Areas
- In‑vitro diagnostics development and commercialization
- Molecular diagnostics and genetic susceptibility testing
- Immunoassay development (ELISA, IFA, line immunoassay, lateral flow)
- Turbidimetric assay development for gastroenterological biomarkers
Key Technologies
- Enzyme‑linked immunosorbent assay (ELISA)
- Indirect immunofluorescence assay (IFA)
- Line immunoassay
- Immunochromatographic lateral‑flow rapid tests